- Home
- WY vs TEVA Comparison
WY vs TEVA Comparison
Compare WY & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WY
- TEVA
- Stock Information
- Founded
- WY 1900
- TEVA 1901
- Country
- WY United States
- TEVA Israel
- Employees
- WY N/A
- TEVA N/A
- Industry
- WY Real Estate Investment Trusts
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- WY Real Estate
- TEVA Health Care
- Exchange
- WY Nasdaq
- TEVA Nasdaq
- Market Cap
- WY 19.1B
- TEVA 21.2B
- IPO Year
- WY N/A
- TEVA N/A
- Fundamental
- Price
- WY $25.79
- TEVA $19.30
- Analyst Decision
- WY Buy
- TEVA Strong Buy
- Analyst Count
- WY 8
- TEVA 7
- Target Price
- WY $32.88
- TEVA $24.71
- AVG Volume (30 Days)
- WY 3.9M
- TEVA 10.0M
- Earning Date
- WY 10-23-2025
- TEVA 11-05-2025
- Dividend Yield
- WY 3.24%
- TEVA N/A
- EPS Growth
- WY N/A
- TEVA N/A
- EPS
- WY 0.38
- TEVA N/A
- Revenue
- WY $7,036,000,000.00
- TEVA $16,628,000,000.00
- Revenue This Year
- WY $2.37
- TEVA $4.07
- Revenue Next Year
- WY $5.22
- TEVA $0.81
- P/E Ratio
- WY $68.38
- TEVA N/A
- Revenue Growth
- WY N/A
- TEVA 2.08
- 52 Week Low
- WY $24.10
- TEVA $12.47
- 52 Week High
- WY $34.03
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- WY 49.83
- TEVA 69.45
- Support Level
- WY $24.70
- TEVA $18.46
- Resistance Level
- WY $26.35
- TEVA $18.96
- Average True Range (ATR)
- WY 0.55
- TEVA 0.54
- MACD
- WY -0.03
- TEVA 0.08
- Stochastic Oscillator
- WY 50.23
- TEVA 96.94
About WY Weyerhaeuser Company
Weyerhaeuser ranks among the world's largest forest product companies. Following the 2016 sale of its pulp business to International Paper, Weyerhaeuser operates three business segments: timberlands, wood products, and real estate. Weyerhaeuser is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities. Earnings from its wood products segment are subject to federal income tax. Weyerhaeuser acquired fellow timber REIT Plum Creek in 2016.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.